Alzheimer Biomarkers Higher in Women - Top-Institutions - MDSpire

Alzheimer Biomarkers Higher in Women

Researchers identify sex-specific differences in amyloid, tau, and brain structure during the seventh decade of life.

  • By

  • Kathryn Wighton

  • January 30, 2026

  • 3 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, NY

    Key Differentiators

    • Neurology
    • Neuroimaging
    • Alzheimer's Disease Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Neuroimaging

  • #3

    Alzheimer's Disease Research Center at University of California, San Francisco (UCSF)
    Alzheimer's Disease Research Center at University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Neuroimaging

  • #4

    Massachusetts General Hospital - Center for Alzheimer Research and Treatment
    Massachusetts General Hospital - Center for Alzheimer Research and Treatment

    Boston, MA

    Key Differentiators

    • Neurology
    • Alzheimer's Disease
    • Neuroimaging

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Neuroimaging

Original Source(s)

Alzheimer Biomarkers Higher in Women

  • by Kathryn Wighton

  • January 30, 2026

Related Content

Conversational AI for perinatal mental health: promise, limits, and a human-AI stepped-care framework

T1DM Pregnancy Linked to Gum Inflammation

Pregnant patients with type 1 diabetes had higher bleeding-on-probing and plaque levels than healthy controls in a small pilot study, though most other periodontal measures did not differ significantly between groups.

Gestational diabetes mellitus–induced adipokine dysregulation and links to metabolic programming risks